BFC Planning’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.3K Hold
350
– – ﹤0.01% 2316
2026
Q2
$10K Hold
350
– – ﹤0.01% 2370
2026
Q1
$8.6K Hold
350
– – ﹤0.01% 2103
2025
Q4
$9.47K Hold
350
– – ﹤0.01% 2103
2025
Q3
$8.73K Hold
350
– – ﹤0.01% 1986
2025
Q2
$8.38K Hold
350
– – ﹤0.01% 1885
2025
Q1
$8.26K Buy
+350
New +$8.84K ﹤0.01% 1847

Other funds holding FMED

BFC Planning's FMED Position: Q3 2026 in Review

BFC Planning held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q3 2026 at 350 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

BFC Planning first reported a position in FMED in Q1 2025 and has held it in 7 quarters since. 11 funds tracked by Wall St. Rank hold FMED as of Q3 2026.

  • BFC Planning held 350 shares of Fidelity Disruptive Medicine ETF worth $11.3K as of Q3 2026.
  • BFC Planning left its Fidelity Disruptive Medicine ETF share count unchanged in Q3 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2316 holding.
  • BFC Planning first reported a position in Fidelity Disruptive Medicine ETF in Q1 2025 and has held it in 7 quarters since.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.